326 related articles for article (PubMed ID: 25273538)
1. The Autism Spectrum Disorders Stem Cell Resource at Children's Hospital of Orange County: Implications for Disease Modeling and Drug Discovery.
Brick DJ; Nethercott HE; Montesano S; Banuelos MG; Stover AE; Schutte SS; O'Dowd DK; Hagerman RJ; Ono M; Hessl DR; Tassone F; Schwartz PH
Stem Cells Transl Med; 2014 Nov; 3(11):1275-86. PubMed ID: 25273538
[TBL] [Abstract][Full Text] [Related]
2. Cellular and molecular characterization of multiplex autism in human induced pluripotent stem cell-derived neurons.
Lewis EMA; Meganathan K; Baldridge D; Gontarz P; Zhang B; Bonni A; Constantino JN; Kroll KL
Mol Autism; 2019; 10():51. PubMed ID: 31893020
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
[TBL] [Abstract][Full Text] [Related]
4. Cellular reprogramming: a novel tool for investigating autism spectrum disorders.
Kim KY; Jung YW; Sullivan GJ; Chung L; Park IH
Trends Mol Med; 2012 Aug; 18(8):463-71. PubMed ID: 22771169
[TBL] [Abstract][Full Text] [Related]
5. Induced pluripotent stem cells as a tool to study brain circuits in autism-related disorders.
Vitrac A; Cloëz-Tayarani I
Stem Cell Res Ther; 2018 Aug; 9(1):226. PubMed ID: 30139379
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional signatures of participant-derived neural progenitor cells and neurons implicate altered Wnt signaling in Phelan-McDermid syndrome and autism.
Breen MS; Browne A; Hoffman GE; Stathopoulos S; Brennand K; Buxbaum JD; Drapeau E
Mol Autism; 2020 Jun; 11(1):53. PubMed ID: 32560742
[TBL] [Abstract][Full Text] [Related]
7. The Use of Induced Pluripotent Stem Cell Technology to Advance Autism Research and Treatment.
Acab A; Muotri AR
Neurotherapeutics; 2015 Jul; 12(3):534-45. PubMed ID: 25851569
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic Autism: Cellular and Molecular Phenotypes in Pluripotent Stem Cell-Derived Neurons.
Liu X; Campanac E; Cheung HH; Ziats MN; Canterel-Thouennon L; Raygada M; Baxendale V; Pang AL; Yang L; Swedo S; Thurm A; Lee TL; Fung KP; Chan WY; Hoffman DA; Rennert OM
Mol Neurobiol; 2017 Aug; 54(6):4507-4523. PubMed ID: 27356918
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
Prem S; Millonig JH; DiCicco-Bloom E
Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
[TBL] [Abstract][Full Text] [Related]
10. Generation of neural cells from DM1 induced pluripotent stem cells as cellular model for the study of central nervous system neuropathogenesis.
Xia G; Santostefano KE; Goodwin M; Liu J; Subramony SH; Swanson MS; Terada N; Ashizawa T
Cell Reprogram; 2013 Apr; 15(2):166-77. PubMed ID: 23550732
[TBL] [Abstract][Full Text] [Related]
11. Personalized genome sequencing coupled with iPSC technology identifies GTDC1 as a gene involved in neurodevelopmental disorders.
Aksoy I; Utami KH; Winata CL; Hillmer AM; Rouam SL; Briault S; Davila S; Stanton LW; Cacheux V
Hum Mol Genet; 2017 Jan; 26(2):367-382. PubMed ID: 28365779
[TBL] [Abstract][Full Text] [Related]
12. Human stem cell-based models for studying autism spectrum disorder-related neuronal dysfunction.
Cheffer A; Flitsch LJ; Krutenko T; Röderer P; Sokhranyaeva L; Iefremova V; Hajo M; Peitz M; Schwarz MK; Brüstle O
Mol Autism; 2020 Dec; 11(1):99. PubMed ID: 33308283
[TBL] [Abstract][Full Text] [Related]
13. Stem cell-derived neurons from autistic individuals with SHANK3 mutation show morphogenetic abnormalities during early development.
Kathuria A; Nowosiad P; Jagasia R; Aigner S; Taylor RD; Andreae LC; Gatford NJF; Lucchesi W; Srivastava DP; Price J
Mol Psychiatry; 2018 Mar; 23(3):735-746. PubMed ID: 28948968
[TBL] [Abstract][Full Text] [Related]
14. Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects.
Mansur F; Teles E Silva AL; Gomes AKS; Magdalon J; de Souza JS; Griesi-Oliveira K; Passos-Bueno MR; Sertié AL
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299197
[TBL] [Abstract][Full Text] [Related]
15. Modeling the autistic cell: iPSCs recapitulate developmental principles of syndromic and nonsyndromic ASD.
Ben-Reuven L; Reiner O
Dev Growth Differ; 2016 Jun; 58(5):481-91. PubMed ID: 27111774
[TBL] [Abstract][Full Text] [Related]
16. In vitro models for ASD-patient-derived iPSCs and cerebral organoids.
Hohmann SS; Ilieva M; Michel TM
Prog Mol Biol Transl Sci; 2020; 173():355-375. PubMed ID: 32711817
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008.
;
MMWR Surveill Summ; 2012 Mar; 61(3):1-19. PubMed ID: 22456193
[TBL] [Abstract][Full Text] [Related]
18. Modeling the Interplay Between Neurons and Astrocytes in Autism Using Human Induced Pluripotent Stem Cells.
Russo FB; Freitas BC; Pignatari GC; Fernandes IR; Sebat J; Muotri AR; Beltrão-Braga PCB
Biol Psychiatry; 2018 Apr; 83(7):569-578. PubMed ID: 29129319
[TBL] [Abstract][Full Text] [Related]
19. Derivation of autism spectrum disorder-specific induced pluripotent stem cells from peripheral blood mononuclear cells.
DeRosa BA; Van Baaren JM; Dubey GK; Lee JM; Cuccaro ML; Vance JM; Pericak-Vance MA; Dykxhoorn DM
Neurosci Lett; 2012 May; 516(1):9-14. PubMed ID: 22405972
[TBL] [Abstract][Full Text] [Related]
20. Stem cells and modeling of autism spectrum disorders.
Freitas BC; Trujillo CA; Carromeu C; Yusupova M; Herai RH; Muotri AR
Exp Neurol; 2014 Oct; 260():33-43. PubMed ID: 23036599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
